{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:44:36Z","timestamp":1761101076632},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,11,4]],"date-time":"2011-11-04T00:00:00Z","timestamp":1320364800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1007\/s00277-011-1358-1","type":"journal-article","created":{"date-parts":[[2011,11,3]],"date-time":"2011-11-03T07:31:23Z","timestamp":1320305483000},"page":"743-749","source":"Crossref","is-referenced-by-count":21,"title":["Efficacy and safety of oral deferasirox treatment in the posttransplant period for patients who have undergone allogeneic hematopoietic stem cell transplantation (alloHSCT)"],"prefix":"10.1007","volume":"91","author":[{"given":"Serdar","family":"Sivgin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bulent","family":"Eser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sami","family":"Bahcebasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leylagul","family":"Kaynar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatih","family":"Kurnaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elmas","family":"Uzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cigdem","family":"Pala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kemal","family":"Deniz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet","family":"Ozturk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Cetin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Unal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,11,4]]},"reference":[{"key":"1358_CR1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bbmt.2008.11.012","volume":"15","author":"K Kataoka","year":"2009","unstructured":"Kataoka K, Nannya Y, Hangaishi A, Imai Y, Chiba S, Takahashi T, Kurokawa M (2009) Influence of pretransplantation serum ferritin on nonrelapse mortality after myeloablative and nonmyeloablative allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 15:195\u2013204","journal-title":"Biol Blood Marrow Transplant"},{"key":"1358_CR2","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/sj.bmt.1703570","volume":"29","author":"A Alt\u2019es","year":"2002","unstructured":"Alt\u2019es A, Remacha AF, Sureda A, Martino R, Briones J, Canals C, Brunet S, Sierra J, Gimferrer E (2002) Iron overload might increase transplant-related mortality in haemotopoietic stem cell transplantation. Bone Marrow Transplant 29:987\u2013989","journal-title":"Bone Marrow Transplant"},{"key":"1358_CR3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.taap.2004.06.021","volume":"202","author":"G Papanikolaou","year":"2005","unstructured":"Papanikolaou G, Pantopoulos K (2005) Iron metabolism and toxicity. Toxicol Appl Pharmacol 202:199\u2013211","journal-title":"Toxicol Appl Pharmacol"},{"key":"1358_CR4","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/sj.bmt.1704591","volume":"34","author":"AM Evens","year":"2004","unstructured":"Evens AM, Mehta J, Gordon LI (2004) Rust and corrosion in hematopoietic stem cell transplantation: the problem of iron and oxidative stress. Bone Marrow Transplant 34:561\u2013571","journal-title":"Bone Marrow Transplant"},{"issue":"8653","key":"1358_CR5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(89)90264-X","volume":"2","author":"MG Zurlo","year":"1989","unstructured":"Zurlo MG, De Stefano P, Borgna-Pignatti C, Di Palma A, Piga A, Melevendi C, Di Gregorio F, Burattini MG, Terzoli S (1989) Survival and causes of death in thalassaemia major. Lancet 2(8653):27\u201330","journal-title":"Lancet"},{"key":"1358_CR6","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1365-2141.2006.06082.x","volume":"133","author":"G Rahav","year":"2006","unstructured":"Rahav G, Volach V, Shapiro M, Rund D, Rachmilewitz EA, Goldfarb A (2006) Severe infections in thalassaemic patients: prevalence and predisposing factors. Br J Haematol 133:667\u2013674","journal-title":"Br J Haematol"},{"key":"1358_CR7","first-page":"63","volume":"17","author":"PJ McKay","year":"1996","unstructured":"McKay PJ, Murphy JA, Cameron S, Burnett AK, Campbell M, Tansey P, Franklin IM (1996) Iron overload and liver dysfunction after allogeneic or autologous bone marrow transplantation. Bone Marrow Transplant 17:63\u201368","journal-title":"Bone Marrow Transplant"},{"key":"1358_CR8","doi-asserted-by":"crossref","unstructured":"Beutler E, Hoffbrand AV, Cook JD (2003) Hematology iron deficiency and overload. Hematology Am Soc Hematol Educ Program 40\u201361","DOI":"10.1182\/asheducation-2003.1.40"},{"key":"1358_CR9","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/bmt.2008.193","volume":"42","author":"GT Sucak","year":"2008","unstructured":"Sucak GT, Yegin ZA, Ozkurt ZN, Aki SN, Karakan T, Akyol G (2008) The role of liver biopsy in the workup of liver dysfunction late after SCT: is the role of iron overload underestimated? Bone Marrow Transplant 42:461\u2013467","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"1358_CR10","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/bmt.2009.88","volume":"44","author":"JW Lee","year":"2009","unstructured":"Lee JW, Kang HJ, Kim EK, Kim H, Shin HY, Ahn HS (2009) Effect of iron overload and iron-chelating therapy on allogeneic hematopoietic SCT in children. Bone Marrow Transplant 44(12):793\u2013797","journal-title":"Bone Marrow Transplant"},{"key":"1358_CR11","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.bbmt.2008.04.009","volume":"14","author":"NS Majhail","year":"2008","unstructured":"Majhail NS, DeFor T, Lazarus HM, Burns LJ (2008) High prevalence of iron overload in adult allogeneic hematopoietic cell transplant survivors. Biol Blood Marrow Transplant 14:790\u2013794","journal-title":"Biol Blood Marrow Transplant"},{"key":"1358_CR12","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1080\/10428190903144659","volume":"50","author":"H Joachim Deeg","year":"2009","unstructured":"Joachim Deeg H, Spaulding E, Shulman HM (2009) Iron overload, hematopoietic cell transplantation, and graft-versus-host disease. Leuk Lymphoma 50:1566\u20131572","journal-title":"Leuk Lymphoma"},{"key":"1358_CR13","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1182\/blood-2003-03-0807","volume":"102","author":"BP Esposito","year":"2003","unstructured":"Esposito BP, Breuer W, Sirankapracha P, Pootrakul P, Hershko C, Cabantchik ZI (2003) Labile plasma iron in iron overload: redox activity and susceptibility to chelation. Blood 102:2670\u20132677","journal-title":"Blood"},{"key":"1358_CR14","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1365-2141.2006.06273.x","volume":"135","author":"J Parkkinen","year":"2006","unstructured":"Parkkinen J, Sahlstedt L, von Bonsdorff L, Salo H, Ebeling F, Ruutu T (2006) Effect of repeated apotransferrin administrations on serum iron parameters in patients undergoing myeloablative conditioning and allogeneic stem cell transplantation. Br J Haematol 135:228\u2013234","journal-title":"Br J Haematol"},{"key":"1358_CR15","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1182\/blood-2006-10-054924","volume":"109","author":"P Armand","year":"2007","unstructured":"Armand P, Kim HT, Cutler CS, Ho VT, Koreth J, Alyea EP, Soiffer RJ, Antin JH (2007) Prognostic impact of elevated pretransplant serum ferritin in patients undergoing myeloablative stem cell transplantation. Blood 109:4586\u20134588","journal-title":"Blood"},{"key":"1358_CR16","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/sj.bmt.1703570","volume":"12","author":"A Alt\u00e8s","year":"2002","unstructured":"Alt\u00e8s A, Remacha AF, Sureda A, Martino R, Briones J, Canals C, Brunet S, Sierra J, Gimferrer E (2002) Iron overload might increase transplant-related mortality in haematopoietic stem cell transplantation. Bone Marrow Transplant 12:987\u2013989","journal-title":"Bone Marrow Transplant"},{"key":"1358_CR17","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/bmt.2009.383","volume":"45","author":"E Ozyilmaz","year":"2010","unstructured":"Ozyilmaz E, Aydogdu M, Sucak G, Aki SZ, Ozkurt ZN, Yegin ZA, Kokturk N (2010) Risk factors for fungal pulmonary infections in hematopoietic stem cell transplantation recipients: the role of iron overload. Bone Marrow Transplant 45:1528\u20131533","journal-title":"Bone Marrow Transplant"},{"key":"1358_CR18","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/bmt.2008.262","volume":"42","author":"V Pullarkat","year":"2008","unstructured":"Pullarkat V, Blanchard S, Tegtmeier B, Dagis A, Patane K, Ito J, Forman SJ (2008) Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 42:799\u2013805","journal-title":"Bone Marrow Transplant"},{"key":"1358_CR19","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/sj.bmt.1701885","volume":"24","author":"J Maertens","year":"1999","unstructured":"Maertens J, Demuynck H, Verbeken EK, Zach\u00e9e P, Verhoef GE, Vandenberghe P, Boogaerts MA (1999) Mucormycosis in allogeneic bone marrow transplant recipients: report of five cases and review of the role of iron overload in the pathogenesis. Bone Marrow Transplant 24:307\u2013312","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl 2","key":"1358_CR20","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0268-960X(08)70005-5","volume":"22","author":"T Witte de","year":"2008","unstructured":"de Witte T (2008) The role of iron in patients after bone marrow transplantation. Blood Rev 22(Suppl 2):22\u201328","journal-title":"Blood Rev"},{"key":"1358_CR21","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00277-007-0266-x","volume":"86","author":"A Altes","year":"2007","unstructured":"Altes A, Remacha AF, Sarda P, Baiget M, Sureda A, Martino R, Briones J, Brunet S, Canals C, Sierra J (2007) Early clinical impact of iron overload in stem cell transplantation: a prospective study. Ann Hematol 86:443\u2013447","journal-title":"Ann Hematol"},{"key":"1358_CR22","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/00007890-199607150-00012","volume":"62","author":"N Azar","year":"1996","unstructured":"Azar N, Valla D, Abdel-Samad I, Hoang C, Fretz C, Sutton L, Fournel JJ, Le Charpentier Y, Binet JL, Leblond V (1996) Liver dysfunction in allogeneic bone marrow transplantation recipients. Transplantation 62:56\u201361","journal-title":"Transplantation"},{"key":"1358_CR23","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1182\/blood-2009-03-212282","volume":"114","author":"SC Maradei","year":"2009","unstructured":"Maradei SC, Maiolino A, de Azevedo AM, Colares M, Bouzas LF, Nucci M (2009) Serum ferritin as risk factor for sinusoidal obstruction syndrome of the liver in patients undergoing hematopoietic stem cell transplantation. Blood 114:1270\u20131275","journal-title":"Blood"},{"key":"1358_CR24","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/10245332.1999.11746478","volume":"4","author":"M Morado","year":"2000","unstructured":"Morado M, Ojeda E, Garcia-Bustos J, Aguado MJ, Arrieta R, Quevedo E, Navas A, Hernandez-Navarro F (2000) BMT: serum ferritin as risk factor for veno-occlusive disease of the liver. Prospective cohort study. Hematology 4:505\u2013512","journal-title":"Hematology"},{"key":"1358_CR25","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3324\/haematol.2009.011429","volume":"95","author":"EP Alessandrino","year":"2010","unstructured":"Alessandrino EP, Della Porta MG, Bacigalupo A, Malcovati L, Angelucci E, Van Lint MT, Falda M, Onida F, Bernardi M, Guidi S, Lucarelli B, Rambaldi A, Cerretti R, Marenco P, Pioltelli P, Pascutto C, Oneto R, Pirolini L, Fanin R, Bosi A (2010) Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study. Haematologica 95:476\u2013484","journal-title":"Haematologica"},{"key":"1358_CR26","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/bmt.2009.77","volume":"44","author":"A Mahindra","year":"2009","unstructured":"Mahindra A, Sobecks R, Rybicki L, Pohlman B, Dean R, Andresen S, Kalaycio M, Sweetenham J, Bolwell B, Copelan E (2009) Elevated pretransplant serum ferritin is associated with inferior survival following nonmyeloablative allogeneic transplantation. Bone Marrow Transplant 44:767\u2013768","journal-title":"Bone Marrow Transplant"},{"key":"1358_CR27","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.bbmt.2006.01.004","volume":"12","author":"RT Kamble","year":"2006","unstructured":"Kamble RT, Selby GB, Mims M, Kharfan-Dabaja MA, Ozer H, George JN (2006) Iron overload manifesting as apparent exacerbation of hepatic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 12:506\u2013510","journal-title":"Biol Blood Marrow Transplant"},{"key":"1358_CR28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1309\/4A4U-N4GL-DRP3-EQPD","volume":"118","author":"MD Shirin Nash","year":"2002","unstructured":"Shirin Nash MD, Marconi S, Krystyna Sikorska MD, Rizwan Naeem MD, Nash G (2002) Role of liver biopsy in the diagnosis of hepatic iron overload in the era of genetic testing. Am J Clin Pathol 118:73\u201381","journal-title":"Am J Clin Pathol"},{"key":"1358_CR29","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1182\/blood.V90.3.994","volume":"90","author":"E Angelucci","year":"1997","unstructured":"Angelucci E, Muretto P, Lucarelli G, Ripalti M, Baronciani D, Erer B et al (1997) Phlebotomy to reduce iron overload in patients cured of thalassemia by bone marrow transplantation. Italian Cooperative Group for Phlebotomy Treatment of Transplanted Thalassemia Patients. Blood 90:994\u2013998","journal-title":"Blood"},{"key":"1358_CR30","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/sj.bmt.1702212","volume":"25","author":"CK Li","year":"2000","unstructured":"Li CK, Lai DH, Shing MMK et al (2000) Early iron reduction programme for thalassaemia patients after bone marrow transplantation. Bone Marrow Transplant 25:653\u2013656","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl 2","key":"1358_CR31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0268-960X(08)70007-9","volume":"22","author":"MD Cappellini","year":"2008","unstructured":"Cappellini MD (2008) Long-term efficacy and safety of deferasirox. Blood Rev 22(Suppl 2):35\u201341","journal-title":"Blood Rev"},{"key":"1358_CR32","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.bbmt.2010.01.004","volume":"16","author":"NS Majhail","year":"2010","unstructured":"Majhail NS, Lazarus HM, Burns LJ (2010) A prospective study of iron-overload management in allogeneic hematopoietic-cell transplant survivors. Biol Blood Marrow Transplant 16:832\u2013837","journal-title":"Biol Blood Marrow Transplant"},{"key":"1358_CR33","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/ajh.21119","volume":"83","author":"E Vichinsky","year":"2008","unstructured":"Vichinsky E (2008) Clinical application of deferasirox: practical patient management. Am J Hematol 83:398\u2013402","journal-title":"Am J Hematol"},{"key":"1358_CR34","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1080\/10428190903144659","volume":"50","author":"HJ Deeg","year":"2009","unstructured":"Deeg HJ, Spaulding E, Shulman HM (2009) Iron overload, hematopoietic cell transplantation, and graft-versus-host disease. Leuk Lymphoma 50:1566\u20131572","journal-title":"Leuk Lymphoma"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-011-1358-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-011-1358-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-011-1358-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T00:41:42Z","timestamp":1593218502000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-011-1358-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,4]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["1358"],"URL":"https:\/\/doi.org\/10.1007\/s00277-011-1358-1","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,4]]}}}